Skip to main content
OpenTrials

Clinical trial condition

Sweat Gland Diseases

Explore clinical trials studying Sweat Gland Diseases. Study availability and eligibility vary by location and protocol.

287 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Sweat Gland Diseases trial results

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT06959225

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Investigative Site US020 Phoenix, Arizona, United States
  • Investigative Site US033 Scottsdale, Arizona, United States
  • Investigative Site US054 Tempe, Arizona, United States
  • Investigative Site US002 Fayetteville, Arkansas, United States
View all 101 locations
View Trial Details
Active, not recruiting

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

NCT05921994

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Rheinstetten, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Haßfurt, Bavaria, Germany
  • Novartis Investigative Site Kulmbach, Bavaria, Germany
View all 80 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Investigative Site US257 Birmingham, Alabama, United States
  • Investigative Site US218 Birmingham, Alabama, United States
  • Investigative Site US239 Montgomery, Alabama, United States
  • Investigative Site US215 Phoenix, Arizona, United States
View all 107 locations
View Trial Details
Active, not recruiting

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

NCT06785675

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Abu Dhabi, United Arab Emirates
  • Novartis Investigative Site Ras al-Khaimah, United Arab Emirates
  • Novartis Investigative Site Sharjah city, United Arab Emirates
View Trial Details
Active, not recruiting

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

NCT06517732

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Novartis Investigative Site Izhevsk, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kaliningrad, Russia
  • Novartis Investigative Site Kazan', Russia
View all 19 locations
View Trial Details
Active, not recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT03661866

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +35 more
Locations
  • Clear Dermatology & Aesthetics Center/Investigative MD Scottsdale, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Arkansas Dermatology Little Rock, Arkansas, United States
View all 62 locations
View Trial Details
Active, not recruiting

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

NCT06361836

Conditions
Autoimmune Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • SLUCare Academic Pavillion St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, not recruiting

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

NCT05139602

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Medical Dermatology Specialists /ID# 240641 Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 241030 Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research /ID# 240811 Hot Springs, Arkansas, United States
  • UCSF Fresno /ID# 240903 Fresno, California, United States
View all 54 locations
View Trial Details
Active, not recruiting

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT03827798

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations
  • Olympian Clinical Research Clearwater, Florida, United States
  • Park Avenue Dermatology PA Orange Park, Florida, United States
  • University Of South Florida Tampa, Florida, United States
  • Advanced Medical Research Sandy Springs, Georgia, United States
View all 36 locations
View Trial Details

Related conditions